Dmitry Y. Tyrsin
Chief Executive Officer at TheraMAB LLC
Dmitry Y. Tyrsin active positions
Companies | Position | Start | End |
---|---|---|---|
TheraMAB LLC
TheraMAB LLC BiotechnologyHealth Technology TheraMAB LLC develops immunotherapeutic monoclonal antibody. It focuses on the development of potential drug that, by its unique capacity to selectively modulate the activity of T-lymphocytes, may provide new treatment options for major diseases in the field of autoimmunity and cancer. The company was founded in August 2009 and is headquartered in Moscow, Russia. | Chief Executive Officer | - | - |
Career history of Dmitry Y. Tyrsin
Former positions of Dmitry Y. Tyrsin
Companies | Position | Start | End |
---|---|---|---|
ChemDiv, Inc.
ChemDiv, Inc. Miscellaneous Commercial ServicesCommercial Services ChemDiv, Inc. operates as a discovery and development contract research organization. It specializes in early and clinical development of anti-infectives and antivirals, oncologics, CNS, cardiometabolics, and anti-inflammatory therapies. The firm?s services include synthetic chemistry, structural biology and structure-based drug discovery, molecular modeling, medicinal chemistry, scale-up, biochemical and cellular assay development, analytical/bioanalytical platforms, ADME/tox, DMPK, and multiple in vivo efficacy/tox models. The company was founded by Alexander Ivachtchenko in 1991 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 2007-12-31 | 2007-12-31 |
Training of Dmitry Y. Tyrsin
Julius-Maximilians-Universität Würzburg | Doctorate Degree |
Moscow State University Lomonosov | Graduate Degree |
Statistics
International
Russia | 3 |
United States | 2 |
Germany | 2 |
Operational
Chief Executive Officer | 1 |
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Sectoral
Consumer Services | 3 |
Health Technology | 2 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
TheraMAB LLC
TheraMAB LLC BiotechnologyHealth Technology TheraMAB LLC develops immunotherapeutic monoclonal antibody. It focuses on the development of potential drug that, by its unique capacity to selectively modulate the activity of T-lymphocytes, may provide new treatment options for major diseases in the field of autoimmunity and cancer. The company was founded in August 2009 and is headquartered in Moscow, Russia. | Health Technology |
ChemDiv, Inc.
ChemDiv, Inc. Miscellaneous Commercial ServicesCommercial Services ChemDiv, Inc. operates as a discovery and development contract research organization. It specializes in early and clinical development of anti-infectives and antivirals, oncologics, CNS, cardiometabolics, and anti-inflammatory therapies. The firm?s services include synthetic chemistry, structural biology and structure-based drug discovery, molecular modeling, medicinal chemistry, scale-up, biochemical and cellular assay development, analytical/bioanalytical platforms, ADME/tox, DMPK, and multiple in vivo efficacy/tox models. The company was founded by Alexander Ivachtchenko in 1991 and is headquartered in San Diego, CA. | Commercial Services |
- Stock Market
- Insiders
- Dmitry Y. Tyrsin
- Experience